Cargando…
Madelung’s Disease: Analysis of Clinical Characteristics, Fatty Mass Distribution, Comorbidities and Treatment of 54 Patients in China
PURPOSE: Madelung’s disease (MD) is a rare disease characterized by the deposition of unencapsulated fat masses on the face, neck, chest, back and other areas of patients. The aim of the study was to analyze the clinical characteristics, comorbidities and treatment of MD in Chinese populations. PATI...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364939/ https://www.ncbi.nlm.nih.gov/pubmed/35966829 http://dx.doi.org/10.2147/DMSO.S363836 |
_version_ | 1784765243269840896 |
---|---|
author | Li, Runze Wang, Chuanxiao Bu, Quandong Pu, Wenshen Zhou, Bin Che, Lin Zhang, Hui Xu, Yan Luan, Hong |
author_facet | Li, Runze Wang, Chuanxiao Bu, Quandong Pu, Wenshen Zhou, Bin Che, Lin Zhang, Hui Xu, Yan Luan, Hong |
author_sort | Li, Runze |
collection | PubMed |
description | PURPOSE: Madelung’s disease (MD) is a rare disease characterized by the deposition of unencapsulated fat masses on the face, neck, chest, back and other areas of patients. The aim of the study was to analyze the clinical characteristics, comorbidities and treatment of MD in Chinese populations. PATIENTS AND METHODS: We retrospectively reviewed the medical records of 54 patients who were diagnosed with MD at the Affiliated Hospital of Qingdao University and Qingdao Municipal Hospital from January 2005 to February 2021 and collected the subjects’ demographic information, clinical indicators, location of fat deposits, treatment, complications and prognostic data. RESULTS: Among 54 MD patients in the study, only 1 (1.85%) was female, and the subjects had an average age of 56.65 ± 7.93 years. More than 70% of patients had a history of long-term smoking or/and alcohol abuse. In our study, type I accounted for approximately 61.11% of cases according to Donhauser’s classification, and almost all patients had neck fat deposition. MD patients often have multiple comorbidities across several systems, such as the endocrine, digestive, circulatory, urinary, and neurological systems. Among these, endocrine system diseases were the most common comorbidities in our study, accounting for 81.48%. Notably, up to 20.37% of cases were complicated with cancer, especially digestive system tumors. More than 70% of the patients received surgical treatment, and nearly 40% experienced postoperative recurrence. CONCLUSION: Considering that MD patients often have comorbidities of multiple systems and that a small number of cases are even complicated by cancer, we recommend that clinicians comprehensively assess a patient’s condition and complications, advocate that patients quit consuming alcohol and smoking as soon as possible, establish healthy dietary and living habits, and formulate individualized and comprehensive diagnosis and treatment plans. |
format | Online Article Text |
id | pubmed-9364939 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-93649392022-08-11 Madelung’s Disease: Analysis of Clinical Characteristics, Fatty Mass Distribution, Comorbidities and Treatment of 54 Patients in China Li, Runze Wang, Chuanxiao Bu, Quandong Pu, Wenshen Zhou, Bin Che, Lin Zhang, Hui Xu, Yan Luan, Hong Diabetes Metab Syndr Obes Original Research PURPOSE: Madelung’s disease (MD) is a rare disease characterized by the deposition of unencapsulated fat masses on the face, neck, chest, back and other areas of patients. The aim of the study was to analyze the clinical characteristics, comorbidities and treatment of MD in Chinese populations. PATIENTS AND METHODS: We retrospectively reviewed the medical records of 54 patients who were diagnosed with MD at the Affiliated Hospital of Qingdao University and Qingdao Municipal Hospital from January 2005 to February 2021 and collected the subjects’ demographic information, clinical indicators, location of fat deposits, treatment, complications and prognostic data. RESULTS: Among 54 MD patients in the study, only 1 (1.85%) was female, and the subjects had an average age of 56.65 ± 7.93 years. More than 70% of patients had a history of long-term smoking or/and alcohol abuse. In our study, type I accounted for approximately 61.11% of cases according to Donhauser’s classification, and almost all patients had neck fat deposition. MD patients often have multiple comorbidities across several systems, such as the endocrine, digestive, circulatory, urinary, and neurological systems. Among these, endocrine system diseases were the most common comorbidities in our study, accounting for 81.48%. Notably, up to 20.37% of cases were complicated with cancer, especially digestive system tumors. More than 70% of the patients received surgical treatment, and nearly 40% experienced postoperative recurrence. CONCLUSION: Considering that MD patients often have comorbidities of multiple systems and that a small number of cases are even complicated by cancer, we recommend that clinicians comprehensively assess a patient’s condition and complications, advocate that patients quit consuming alcohol and smoking as soon as possible, establish healthy dietary and living habits, and formulate individualized and comprehensive diagnosis and treatment plans. Dove 2022-08-06 /pmc/articles/PMC9364939/ /pubmed/35966829 http://dx.doi.org/10.2147/DMSO.S363836 Text en © 2022 Li et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Li, Runze Wang, Chuanxiao Bu, Quandong Pu, Wenshen Zhou, Bin Che, Lin Zhang, Hui Xu, Yan Luan, Hong Madelung’s Disease: Analysis of Clinical Characteristics, Fatty Mass Distribution, Comorbidities and Treatment of 54 Patients in China |
title | Madelung’s Disease: Analysis of Clinical Characteristics, Fatty Mass Distribution, Comorbidities and Treatment of 54 Patients in China |
title_full | Madelung’s Disease: Analysis of Clinical Characteristics, Fatty Mass Distribution, Comorbidities and Treatment of 54 Patients in China |
title_fullStr | Madelung’s Disease: Analysis of Clinical Characteristics, Fatty Mass Distribution, Comorbidities and Treatment of 54 Patients in China |
title_full_unstemmed | Madelung’s Disease: Analysis of Clinical Characteristics, Fatty Mass Distribution, Comorbidities and Treatment of 54 Patients in China |
title_short | Madelung’s Disease: Analysis of Clinical Characteristics, Fatty Mass Distribution, Comorbidities and Treatment of 54 Patients in China |
title_sort | madelung’s disease: analysis of clinical characteristics, fatty mass distribution, comorbidities and treatment of 54 patients in china |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364939/ https://www.ncbi.nlm.nih.gov/pubmed/35966829 http://dx.doi.org/10.2147/DMSO.S363836 |
work_keys_str_mv | AT lirunze madelungsdiseaseanalysisofclinicalcharacteristicsfattymassdistributioncomorbiditiesandtreatmentof54patientsinchina AT wangchuanxiao madelungsdiseaseanalysisofclinicalcharacteristicsfattymassdistributioncomorbiditiesandtreatmentof54patientsinchina AT buquandong madelungsdiseaseanalysisofclinicalcharacteristicsfattymassdistributioncomorbiditiesandtreatmentof54patientsinchina AT puwenshen madelungsdiseaseanalysisofclinicalcharacteristicsfattymassdistributioncomorbiditiesandtreatmentof54patientsinchina AT zhoubin madelungsdiseaseanalysisofclinicalcharacteristicsfattymassdistributioncomorbiditiesandtreatmentof54patientsinchina AT chelin madelungsdiseaseanalysisofclinicalcharacteristicsfattymassdistributioncomorbiditiesandtreatmentof54patientsinchina AT zhanghui madelungsdiseaseanalysisofclinicalcharacteristicsfattymassdistributioncomorbiditiesandtreatmentof54patientsinchina AT xuyan madelungsdiseaseanalysisofclinicalcharacteristicsfattymassdistributioncomorbiditiesandtreatmentof54patientsinchina AT luanhong madelungsdiseaseanalysisofclinicalcharacteristicsfattymassdistributioncomorbiditiesandtreatmentof54patientsinchina |